Crossmark

The epidermal growth factor receptor inhibitor gefitinib enhances in vitro and in vivo sensory axon regeneration and functional recovery following transection in a mouse median nerve injury model

Crossref DOI link: https://doi.org/10.1002/mus.28291

Published Online: 2024-11-11

Published Print: 2025-01

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Topley, Maxwell https://orcid.org/0009-0002-1050-4360
Sparks, Payton https://orcid.org/0009-0001-1230-0997
Crotty, Anne‐Marie

Kawaja, Michael

Hendry, J. Michael https://orcid.org/0009-0004-0108-9120
License Information

Version of Record valid from 2024-11-11
More Information

Publication History

Received: 2024-04-12

Accepted: 2024-10-23

Published: 2024-11-11